Opko Health Inc (NYSE:OPK) institutional sentiment decreased to 1.03 in Q2 2017. 119.98 million shares or 1.70% less from 122.05 million shares in 2017Q1 were reported. IFC Holdings Incorporated FL raised its position in Opko Health by 16.5% during the second quarter. Sold All: 33 Reduced: 55 Increased: 65 New Position: 26.
Many analysts have provided their estimated foresights on Opko Health, Inc. The company has market cap of $3.89 billion. Its segments include Pharmaceutical, Diagnostics and Corporate. It now has negative earnings. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations.
Taking a broader look at the analyst consensus, according to 6 analysts Opko Health Inc (NASDAQ:OPK)'s price will reach at $13.25 during 52 weeks. Accern also assigned press coverage about the biotechnology company an impact score of 45.5740286609964 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. For the current quarter Opko Health Inc (NASDAQ:OPK) has high EPS estimates of $-0.03 in contradiction of low EPS estimates of $-0.07. It has underperformed by 49.32% the S&P500.
Opko Health Inc (NASDAQ:OPK) has average revenue estimates of $319.43 Million, compared to low analyst estimates of $309.5 Million and high estimates of $331.7 Million for the current quarter. (NASDAQ:OPK) to report on November, 6. its quarterly earnings Wall Street analysts expect $-0.07 earnings per share, down $0.04 or 133.33 % from last year's $-0.03 same quarter earnings.
Whereas they predicted High and Low Earnings Estimate as $-0.03 and $-0.07 respectively.
08/17/2017 - Cantor Fitzgerald began new coverage on Opko Health Inc giving the company a "overweight" rating. Following the purchase, the chief executive officer now owns 3,068,951 shares of the company's stock, valued at approximately $19,702,665.42. HOLI's SI was 1.49 million shares in October as released by FINRA. Mivtachim The Workers Social Insurance Fund Ltd. Hedge funds and other institutional investors own 22.45% of the company's stock.
Since January 1, 0001, it had 28 buys, and 0 insider sales for $15.23 million activity.
Ratings analysis reveals 73% of Opko Health's analysts are positive. Its minimum price target estimates has been figured out at $6.5 while the maximum price target forecast is established at $20. OPK was included in 16 notes of analysts from August 11, 2015. The company was maintained on Friday, June 16 by Ladenburg. The rating was maintained by Ladenburg with "Buy" on Tuesday, June 6. BidaskClub upgraded Opko Health from a "sell" rating to a "hold" rating in a report on Saturday, September 23rd. JP Morgan downgraded it to "Neutral" rating and $7 target in Thursday, September 14 report. The New Jersey-based Bessemer Group Inc Inc has invested 0% in Opko Health Inc. (NASDAQ:OPK) earned "Buy" rating by Laidlaw on Wednesday, August 12. (NASDAQ:OPK). Lpl Limited Liability Company holds 0% or 15,988 shares in its portfolio. Eqis Management holds 0.01% of its portfolio in Opko Health Inc. (NASDAQ:OPK) on Tuesday, September 12 with "Hold" rating. The firm earned "Outperform" rating on Thursday, March 31 by Barrington Research. "(OPK) Rating Lowered to Sell at Zacks Investment Research" was published by BBNS and is the sole property of of BBNS. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company's stock.
More recent Opko Health Inc.
Receive Opko Health Inc News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc with MarketBeat.com's FREE daily email newsletter. Globenewswire.com's news article titled: "OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and ..." with publication date: October 12, 2017 was also an interesting one.